Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease.
Saved in:
| Title: | Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease. |
|---|---|
| Authors: | Song J; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Yang RR; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; Shanghai Institute for Advanced Immunochemical Studies, and School of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China., Chang J; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Liu YD; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Lu CH; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Chen LF; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China., Guo H; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China., Zhang YH; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China., Fan ZS; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Zhou JY; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Zhou GZ; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Zhang KK; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Luo XM; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Chen KX; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Jiang HL; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. hljiang@simm.ac.cn.; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. hljiang@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. hljiang@simm.ac.cn.; Shanghai Institute for Advanced Immunochemical Studies, and School of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China. hljiang@simm.ac.cn.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. hljiang@simm.ac.cn., Zhang SL; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. slzhang@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. slzhang@simm.ac.cn., Zheng MY; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. myzheng@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. myzheng@simm.ac.cn.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. myzheng@simm.ac.cn. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2023 Apr; Vol. 44 (4), pp. 791-800. Date of Electronic Publication: 2022 Oct 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36229599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Song+J%22">Song J</searchLink>; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.<br /><searchLink fieldCode="AU" term="%22Yang+RR%22">Yang RR</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; Shanghai Institute for Advanced Immunochemical Studies, and School of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China.<br /><searchLink fieldCode="AU" term="%22Chang+J%22">Chang J</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.<br /><searchLink fieldCode="AU" term="%22Liu+YD%22">Liu YD</searchLink>; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Lu+CH%22">Lu CH</searchLink>; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Chen+LF%22">Chen LF</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.<br /><searchLink fieldCode="AU" term="%22Zhang+YH%22">Zhang YH</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.<br /><searchLink fieldCode="AU" term="%22Fan+ZS%22">Fan ZS</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Zhou+JY%22">Zhou JY</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Zhou+GZ%22">Zhou GZ</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Zhang+KK%22">Zhang KK</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Luo+XM%22">Luo XM</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Chen+KX%22">Chen KX</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.<br /><searchLink fieldCode="AU" term="%22Jiang+HL%22">Jiang HL</searchLink>; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. hljiang@simm.ac.cn.; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. hljiang@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. hljiang@simm.ac.cn.; Shanghai Institute for Advanced Immunochemical Studies, and School of Life Science and Technology, Shanghai Tech University, Shanghai, 200031, China. hljiang@simm.ac.cn.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. hljiang@simm.ac.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+SL%22">Zhang SL</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. slzhang@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. slzhang@simm.ac.cn.<br /><searchLink fieldCode="AU" term="%22Zheng+MY%22">Zheng MY</searchLink>; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. myzheng@simm.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. myzheng@simm.ac.cn.; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. myzheng@simm.ac.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100956087%22">Acta pharmacologica Sinica</searchLink> [Acta Pharmacol Sin] 2023 Apr; Vol. 44 (4), pp. 791-800. <i>Date of Electronic Publication: </i>2022 Oct 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100956087 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-7254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216714083%22">16714083 </searchLink><i>NLM ISO Abbreviation: </i>Acta Pharmacol Sin <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36229599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41401-022-01002-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 791 Titles: – TitleFull: Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Song J – PersonEntity: Name: NameFull: Yang RR – PersonEntity: Name: NameFull: Chang J – PersonEntity: Name: NameFull: Liu YD – PersonEntity: Name: NameFull: Lu CH – PersonEntity: Name: NameFull: Chen LF – PersonEntity: Name: NameFull: Guo H – PersonEntity: Name: NameFull: Zhang YH – PersonEntity: Name: NameFull: Fan ZS – PersonEntity: Name: NameFull: Zhou JY – PersonEntity: Name: NameFull: Zhou GZ – PersonEntity: Name: NameFull: Zhang KK – PersonEntity: Name: NameFull: Luo XM – PersonEntity: Name: NameFull: Chen KX – PersonEntity: Name: NameFull: Jiang HL – PersonEntity: Name: NameFull: Zhang SL – PersonEntity: Name: NameFull: Zheng MY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2023 Apr Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1745-7254 Numbering: – Type: volume Value: 44 – Type: issue Value: 4 Titles: – TitleFull: Acta pharmacologica Sinica Type: main |
| ResultId | 1 |